Canoy, Ariene P.
HRN: 27-17-54 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/24/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/24/2025
05/31/2025
IVTT
Q8H
Q8H
Cholecystitis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes